Connor, Clark & Lunn Investment Management (CC&L)’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,458
Closed -$1M 1675
2024
Q1
$1M Buy
+4,458
New +$1.01M ﹤0.01% 889
2022
Q3
Sell
-12,973
Closed -$2.67M 1244
2022
Q2
$2.67M Buy
+12,973
New +$2.93M 0.02% 426
2020
Q3
Sell
-6,876
Closed -$1.05M 1110
2020
Q2
$1.05M Buy
+6,876
New +$1.05M 0.01% 600
2019
Q4
Sell
-11,575
Closed -$1.67M 1080
2019
Q3
$1.67M Buy
+11,575
New +$1.73M 0.01% 449
2015
Q2
Sell
-3,000
Closed -$211K 658
2015
Q1
$211K Buy
+3,000
New +$198K ﹤0.01% 498

Other funds holding STE

Connor, Clark & Lunn Investment Management (CC&L)'s STE Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Steris (STE) in Q2 2024, closing a stake of 4,458 shares — an estimated $1M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in STE in Q1 2015 and held it in 5 quarters. The position peaked at $2.67M in Q2 2022. 747 funds tracked by Wall St. Rank hold STE as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Steris position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 4,458 Steris shares in Q2 2024, an estimated $1M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Steris in Q1 2015 and held it in 5 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Steris position peaked at $2.67M in Q2 2022.
  • 747 funds tracked by Wall St. Rank held Steris as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.